Tech Science® for life
People are at the heart of our business and their lives are our reason for being.
Science Valley is a multicentric management company, unprecedented in the world, which offers intelectual and technical scientific services in the field of intelligence in clinical research and R&D services for the development of pharmaceutical drugs, raw materials, new treatments, high medical-scientific education, surgical procedures, vaccines, cost-effectiveness studies and devices for human health.
People are at the heart of our business and their lives are our reason for being.
Study design, planning, management and biopharmaceutial tests execution
Recruitment, data management and preventive monitoring of trial patients
Technical regulatory support for protocols approvals, registration, manufacturing and marketing
Pre-clinical, clinical research and R&D to create new drugs, molecules, innovative treatments and pharmacovigilance
Paper publications of clinical studies and scientific articles in renowned scientific journals
Clinical trials for life.
We work on clinical trials, conducting scientific studies in which new treatments (drugs, procedures, diagnoses and other therapies) are tested on patients/trial participants to determine if they are safe and effective. These tests are all approved by IRBs and help scientists answer essential questions about new therapies: What diseases are the are treatments for?What doses are most effective? What kind of patients can benefit from them? Most drugs in use are currently tested and made available to patients through clinical trials.
More than 2000 patients in more than 90 clinical studies performed. That’s what Science Valley does best: innovation for healthcare.
Twenty seven qualified “Research Centers” in twelve states, skilled to manage all four phases of the Clinical Trials processes (Phase 1, 2, 3 and 4) and in some cases, even Preclinical studies, supporting all the Healthcare community & Pharma Industry (sponsors, physicians, institutions and researchers).
High quality standards in study design, planning and execution of trials, Academic Studies, data treatment and publications, in addition to all related R&D and support for development and Registry of new Pharma drugs, molecules and innovative treatments.
Operational guideline in light of “Good Practices in Research” and Compliance with its all related regulatory affairs (FDA/ANVISA). High quality in recruitment and monitoring of patients panel. Huge track record results and important publications with more than 90 studies with 3000 patients.
Up to 2026, we aim to become the best and greatest Multicenter International Research Institute (MIRI) for Biotechnological areas of interests: RNA, mAbs and Recombinant Proteins focused on Oncology, Cardiology, Endocrinology, Neurology and COVID in addition of Medical Gadgets/Devices.
“The application of biotechnology in the healthcare field has been highlighted. In 2020, the world made efforts to fight coronavirus. Biotechs are the great hope for the creation of an effective vaccine against Covid-19. This ensures large-scale immunization and helps the disease to be eradicated in the world.”
“SVRI will be soon a strong reference for healthcare R&D. We are toward to be one of the disruptive cases in the Life-Science sector. We will be a milestone in the history of science for Research & Development in the pharma industry, contributing for a new generation of medicines/treatments to the world.”